Gabriel Helmlinger
Impact in
- Modeling and Simulation top 1%
- Mathematical Biology Tumor Growth
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 6
-
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Rakesh K. Jain (3 shared papers)Marc Dellian (3 shared papers)Fan Yuan (2 shared papers)Robert J. Melder (1 shared paper)Paolo A. Netti (1 shared paper)Robert M. Nerem (3 shared papers)David W. Boulton (8 shared papers)Peter J. Greasley (5 shared papers)
- Journals
- Frontiers in Immunology (7 papers)CPT Pharmacometrics & Systems Pharmacology (5 papers)Cancer Research (5 papers)Journal of Clinical Oncology (5 papers)Diabetes Obesity and Metabolism (3 papers)
- Partner nations
- United StatesRussiaSweden
In The Last Decade
Gabriel Helmlinger
63 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Modeling and Simulation 325
- Cancer Research 809
- Cell Biology 624
- Endocrinology, Diabetes and Metabolism 487
- Biomaterials 371
Countries citing papers authored by Gabriel Helmlinger
This map shows the geographic impact of Gabriel Helmlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Helmlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Helmlinger more than expected).
Fields of papers citing papers by Gabriel Helmlinger
This network shows the impact of papers produced by Gabriel Helmlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Helmlinger. The network helps show where Gabriel Helmlinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriel Helmlinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation Hit paper breakdown → | 1997 | 1300 |
| 2 | Solid stress inhibits the growth of multicellular tumor spheroids Hit paper breakdown → | 1997 | 648 |
| 3 | Why do Hit paper breakdown → | 2017 | 355 |
| 4 | Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. | 2002 | 342 |
| 5 | 1991 | 222 | |
| 6 | 2000 | 137 | |
| 7 | 1995 | 110 | |
| 8 | 2018 | 83 | |
| 9 | 2017 | 80 | |
| 10 | 2015 | 72 | |
| 11 | 1996 | 63 | |
| 12 | 1996 | 62 | |
| 13 | 2018 | 51 | |
| 14 | 2019 | 46 | |
| 15 | 2005 | 45 | |
| 16 | 2010 | 43 | |
| 17 | 2020 | 33 | |
| 18 | 2019 | 33 | |
| 19 | 2019 | 32 | |
| 20 | 2020 | 32 |
About Gabriel Helmlinger
Gabriel Helmlinger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 65 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (7 papers), T-cell and B-cell Immunology (6 papers), Cancer Genomics and Diagnostics (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Modeling and Simulation (325 citations), Cancer Research (809 citations), Cell Biology (624 citations), Endocrinology, Diabetes and Metabolism (487 citations) and Biomaterials (371 citations). Gabriel Helmlinger has collaborated with scholars based in United States, Russia and Sweden. Frequent co-authors include Rakesh K. Jain, Marc Dellian, Fan Yuan, Robert J. Melder, Paolo A. Netti, Robert M. Nerem, David W. Boulton, Peter J. Greasley, Karen Melissa Hallow and John J.V. McMurray. Their work appears in journals such as Frontiers in Immunology, CPT Pharmacometrics & Systems Pharmacology, Cancer Research, Journal of Clinical Oncology and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.